MRKR Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Marker Therapeutics Inc

Watchlist Manager

Watchlist

Price: 1.68 USD 13.51% Market Closed

Market Cap: $28m

	Marker Therapeutics Inc NASDAQ:MRKR	US
N	Natera Inc F:45E	US
	Akwel SA PAR:AKW	FR
	Apogee Enterprises Inc NASDAQ:APOG	US
	PDD Holdings Inc NASDAQ:PDD	CN
P	Pilgrims Pride Corp F:6PP	US
D	D R Horton Inc F:HO2	US
	MERLIN Properties SOCIMI SA F:MEQA	ES
W	Wilmar International Ltd F:RTH	SG
H	H & M Hennes & Mauritz AB XMUN:HMSB	SE
M	McCormick & Company Inc F:MCX	US
O	Overstock.com Inc F:OVER	US
F	First Advantage Corp F:0MS	US
M	Manulife Financial Corp XBER:MLU	CA

Profitability Summary

Marker Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-351%

Negative 3Y Average Operating Margin

-291%

Declining Operating Margin

-288% > -351%

Negative Net Margin

-343%

Negative 3Y Average Net Margin

-233%

Declining Net Margin

-210% > -343%

Negative Free Cash Flow Margin

-339%

Negative 3Y Average Free Cash Flow Margin

-311%

Free Cash Flow Margin is Increasing

-427% > -339%

Negative ROE

-69%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-426%

Declining ROIC

-144% > -894%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.